Date: 6.9.2013
Technology offer: Specific thrombin inhibitors for the development of anticoagulant
Reference: TOES20130801002
Summary: A Spanish public research organization and a University from Venezuela have developed a new protein with inhibitory activity against thrombin. Compared to other thrombin inhibitors, the protein is most selective and could be used as anticoagulant reducing side effects related to these compounds. Pharmaceutical or biotech companies are sought for further development under a license agreement.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology legislative - Biotech legislative environment search
Biotechnology projecst no.10 - 10th page of our biotechnology projects database
Gene-edited pig kidney transplanted into first living human patient
Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapy